IP Library Granted Patent US 9,597,062
Granted Patent B2
US 9,597,062 · App. 12/988,353 · Granted Mar 21, 2017

Medical devices for delivering fluids during surgery and methods for their use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,597,062
App. No.
12/988,353
Granted
Mar 21, 2017
Kind
B2
Abstract

Provided is a surgical applicator and applicator tip configured to attach in fluid communication, for the delivery of beneficial fluids. The applicator tip may also be configured to reversibly attach, in fluid communication, with a pledget. For example, the applicator tip may include male or female threads, and the pledget has threads that are complementary to the thread configuration of the tip. The applicator tip may further comprise at least one fluid transfer lumen for transfer of a fluid from the tip to the pledget. In one embodiment of the invention, the tip includes male threads and the pledget includes a pledget attachment portion. There are also provided methods for connecting the tip to the pledget. In one embodiment, a tip comprising male threads is attached to the pledget, comprising a pledget attachment portion, by tapping or pressing the tip into the pledget attachment portion. There are also provided methods of use for the attached tip and pledget, including debridement, tissue translocation, delivery of fluid substances, absorption of fluid substances and combinations thereof. In a particular embodiment, the applicator places a thrombin solution into the attached pledget for delivery of an active hemostatic agent to a tissue site.

Claims (62)

1. A device for delivery of a first solution comprising a recombinant protein comprising human thrombin and a second solution to a bleeding surgical site of a human patient, the device comprising:

an applicator comprising at least two fluid delivery lumena in fluid communication with a source of the first solution and a source of the second solution, the applicator having a proximal end and a distal end;

an applicator tip having a proximal end and a distal end and comprising at least two delivery lumena, wherein the applicator tip proximal end is configured to detachably connect to the distal end of the applicator by a semi-pliable flange-mount such that the at least two delivery lumena of the applicator tip are each in fluid communication with the fluid delivery lumen of the applicator; and

a fluid-permeable porous matrix pledget configured to deliver the recombinant protein comprising human thrombin when pressed against the surgical site, wherein the pledget is configured to detachably couple to the applicator tip distal end such that the pledget is in fluid communication with the at least two delivery lumena of the applicator tip;

wherein the device is configured for minimally invasive, laparoscopic delivery of the recombinant protein comprising human thrombin to the surgical site;

wherein the applicator has a rigidity such that a user can manipulate the proximal end of the applicator to apply an effective amount of pressure with the pledget to the surgical site such that bleeding is reduced concurrently while continuously delivering the first solution and the second solution when the pledget is pressed against the surgical site;

wherein the first solution and the second solution delivered from the two delivery lumena mix upon entering the pledget;

wherein the applicator further comprises an interior shaft; and

wherein the distal end of the applicator comprises at least two spring arms comprising retaining teeth to secure the flange mount.

2. The device of claim 1 , wherein at least one fluid delivery lumen of the applicator tip is a branched fluid delivery lumen.

3. The device of claim 1 , wherein the pledget comprises gelatin, a cotton gauze, a sponge, a plastic, fused gelatin beads, or a combination thereof.

4. The device of claim 1 , wherein the pledget comprises biocompatible, bioabsorbable material that, in use, can be left permanently at the surgical site.

5. The device of claim 1 , wherein the applicator tip has a diameter of about 5-15 mm.

6. The device of claim 1 , wherein the applicator tip has a length of about 10-20 mm.

7. The device of claim 1 , wherein the recombinant protein comprising human thrombin comprises 5,000 IU recombinant human thrombin.

8. The device of claim 1 , wherein the first solution and the second solution mix externally to the applicator.

9. The device of claim 1 , wherein the second solution comprises fibrinogen.

10. The device of claim 1 , wherein the flange mount comprises at least two fluid delivery lumena.

11. The device of claim 1 , wherein the interior shaft comprises a tapered tip, such that the tapered tip fits into the flange mount on the proximal end of the applicator tip.

12. The device of claim 1 , further comprising a handle configured to connect to the at least two spring arms, such that squeezing the handle retracts the spring arms and allows the flange mount to be released when the interior shaft advances along the distal end of the applicator.

13. A device for delivery of a first fluid and a second fluid to a bleeding surgical site of a human patient, the device comprising:

an applicator comprising at least two fluid delivery lumena, the applicator having a proximal end and a distal end;

an applicator tip having a proximal end and a distal end and comprising at least two fluid delivery lumena, wherein the applicator tip proximal end is configured to detachably connect to the distal end of the applicator by a semi-pliable flange-mount such that the at least two fluid delivery lumena of the applicator tip are each in fluid communication with the fluid delivery lumen of the applicator; and

a fluid-permeable porous matrix pledget configured to deliver fluid when pressed against the surgical site, wherein the pledget is configured to detachably couple to the applicator tip distal end such that the pledget is in fluid communication with the at least two fluid delivery lumena of the applicator tip;

wherein the device is configured for minimally invasive, laparoscopic delivery of the fluid;

wherein the applicator has a rigidity such that a user can manipulate the proximal end of the applicator to apply an effective amount of pressure with the pledget to the surgical site such that bleeding is reduced concurrently while continuously delivering the first fluid and second fluid when the pledget is pressed against the surgical site;

wherein the first fluid and the second delivered from the two delivery lumena mix upon entering the pledget;

wherein the applicator further comprises an interior shaft; and

wherein the distal end of the applicator comprises at least two spring arms comprising retaining teeth to secure the flange mount.

14. The device of claim 13 , wherein at least one fluid delivery lumen of the applicator tip is a branched fluid delivery lumen.

15. The device of claim 13 , wherein the pledget comprises gelatin, a cotton gauze, a sponge, a plastic, fused gelatin beads, or a combination thereof.

16. The device of claim 13 , wherein the pledget comprises biocompatible, bioabsorbable material that, in use, can be left permanently at the surgical site.

17. The device of claim 13 , wherein the pledget is configured for the mixing of two fluids.

18. The device of claim 13 , wherein the applicator tip has a diameter of about 5-15 mm.

19. The device of claim 13 , wherein the at least two fluid delivery lumena of the applicator are in fluid communication with a source of the first fluid and a source of the second fluid.

20. The device of claim 19 , wherein the first fluid comprises a recombinant protein comprising human thrombin.

21. The device of claim 20 , wherein the second fluid comprises fibrinogen.

22. The device of claim 13 , wherein the device is configured for the delivery of a gel.

23. The device of claim 13 , wherein the first fluid and the second fluid mix externally to the applicator.

24. The device of claim 13 , wherein the flange mount comprises at least two fluid delivery lumena.

25. The device of claim 13 , wherein the interior shaft comprises a tapered tip, such that the tapered tip fits into the flange mount on the proximal end of the applicator tip.

26. The device of claim 13 , further comprising a handle configured to connect to the at least two spring arms, such that squeezing the handle retracts the spring arms and allows the flange mount to be released when the interior shaft advances along the distal end of the applicator.

27. A device for delivery of a first solution comprising a recombinant protein comprising human thrombin and a second solution to a bleeding surgical site of a human patient, the device comprising:

an applicator comprising at least two fluid delivery lumena in fluid communication with a source of the first solution and a source of the second solution,

an applicator tip comprising at least two delivery lumena coupled to the applicator by a semi-pliable flange-mount such that the at least two delivery lumena of the applicator tip are each in fluid communication with the fluid delivery lumen of the applicator; and

a fluid-permeable porous matrix pledget coupled to the applicator tip such that the pledget is in fluid communication with the at least two delivery lumena of the applicator tip, the pledget being configured to deliver the recombinant protein comprising human thrombin when pressed against the surgical site;

wherein the device is configured for minimally invasive, laparoscopic delivery of the recombinant protein comprising human thrombin to the surgical site;

wherein the applicator has a rigidity such that a user can manipulate the proximal end of the applicator to apply an effective amount of pressure with the pledget to the surgical site such that bleeding is reduced concurrently while continuously delivering the first solution and the second solution when the pledget is pressed against the surgical site;

wherein the first solution and the second solution delivered from the two delivery lumena mix upon entering the pledget;

wherein the applicator further comprises an interior shaft; and

wherein the distal end of the applicator comprises at least two spring arms comprising retaining teeth to secure the flange mount.

28. The device of claim 27 , wherein at least one fluid delivery lumen of the applicator tip is a branched fluid delivery lumen.

29. The device of claim 27 , wherein the pledget comprises gelatin, a cotton gauze, a sponge, a plastic, fused gelatin beads, or a combination thereof.

30. The device of claim 27 , wherein the pledget comprises biocompatible, bioabsorbable material that, in use, can be left permanently at the surgical site.

31. The device of claim 27 , wherein the applicator tip has a diameter of about 5-15 mm.

32. The device of claim 27 , wherein the applicator tip has a length of about 5 mm-25 mm.

33. The device of claim 27 , wherein the recombinant protein comprising human thrombin comprises 5,000 IU recombinant human thrombin.

34. The device of claim 27 , wherein the first solution and the second solution mix externally to the applicator.

35. The device of claim 27 , wherein the second solution comprises fibrinogen.

36. The device of claim 27 , wherein the flange mount comprises at least two fluid delivery lumena.

37. The device of claim 27 , wherein the interior shaft comprises a tapered tip, such that the tapered tip fits into the flange mount on the proximal end of the applicator tip.

38. The device of claim 27 , further comprising a handle configured to connect to the at least two spring arms, such that squeezing the handle retracts the spring arms and allows the flange mount to be released when the interior shaft advances along the distal end of the applicator.

Assignments (11)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 043596, FRAME 0259 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; THERAKOS, INC.; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065610/0324 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2018
From: MALLINCKRODT PHARMA IP TRADING DAC
To: BAXTER INTERNATIONAL, INC.
Reel/Frame 045754/0904 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SIGNATORY PAGES ON SUPPORTING DOCUMENT PREVIOUSLY RECORDED AT REEL: 043723 FRAME: 0478. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT. Recorded Oct 3, 2017
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 044570/0091 →
NUNC PRO TUNC ASSIGNMENT Recorded Sep 28, 2017
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 043723/0478 →
NUNC PRO TUNC ASSIGNMENT Recorded Sep 28, 2017
From: THE MEDICINES COMPANY
To: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 043723/0188 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Aug 18, 2017
From: MALLINCKRODT PHARMA IP TRADING DESIGNATED ACTIVITY COMPANY
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 043596/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2017
From: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: MALLINCKRODT PHARMA IP TRADING D.A.C.
Reel/Frame 041119/0963 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2017
From: THE MEDICINES COMPANY
To: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 041119/0930 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2015
From: ZYMOGENETICS, LLC
To: THE MEDICINES COMPANY
Reel/Frame 035988/0724 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2012
From: ZYMOGENETICS, INC.
To: ZYMOGENETICS, LLC
Reel/Frame 029406/0917 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 30, 2010
From: ALEXANDER, WILLIAM ALLAN; BISHOP, PAUL D.; CARTER, STEVE R.; LITTAU, ALISA M.
To: ZYMOGENETICS, INC.
Reel/Frame 025557/0637 →